Innoventric

Ness Ziona, Israel Founded: 2017 • Age: 9 yrs
Transcatheter solutions for heart disease patients are developed.

About Innoventric

Innoventric is a Healthcare company based in Ness Ziona (Israel) founded in 2017 by Rafi Benary. Transcatheter solutions for heart disease patients are developed. Innoventric has raised $41.81 million across 4 funding rounds from investors including RA Capital, European Union and Mivtach Shamir Holdings. Innoventric offers products and services including Trillium, Unica, and Koala. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Innoventric Ltd.

Company details

Founded in 2017 in Ness Ziona, Israel, transcatheter solutions are developed for patients with heart diseases. Focus is placed on percutaneous devices, including the Trillium, which addresses tricuspid regurgitation through minimally invasive procedures. Operations occur within the medical device sector, emphasizing cardiovascular treatments. Geography is centered in Israel, with activities aimed at advancing interventional cardiology options for clinical use.

  • Headquarters Ness Ziona, Israel
  • Founders Rafi Benary
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website innoventric.com
  • Social LinkedIn YouTube
  • Legal Name Innoventric Ltd.
Key Metrics
  • Total Equity Funding
    $41.81M (USD)

    in 4 rounds

  • Latest Funding Round
    $28.5M (USD), Series B

    Oct 2024

  • Investors
    RA Capital

    & 5 more

Products & Services of Innoventric

Innoventric offers a comprehensive portfolio of products and services, including Trillium, Unica, and Koala.

Trillium
Transcatheter Device

Device for quick TR treatment with hemodynamic improvements.

Unica
Transcatheter Device

Heterotopic solution for TR patients via cross-caval technology.

Koala
Transcatheter Device

Supportive device for TR management in clinical settings.

Apps and channels of Innoventric

its YouTube channel PCR has 17.9K subscribers and 30 videos.

PCR
YouTube 17.9K subscribers 30 videos Science & Technology
Open channel

Videos from Innoventric

The most watched videos on Innoventric's YouTube channel, PCR (17.9K subscribers). Click a video to play it here.

Latest learnings on the treatment of asymptomatic severe aortic stenosis from the EARLY TAVR
7.4K views
How to use DCB in coronary bifurcations - Webinar
5.7K views
What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025
2.8K views
Step-by-step TAVI procedure in Europe and India - A review from PCR and India Valves - Webinar
2.2K views

More on PCR.

Funding Insights of Innoventric

Innoventric has successfully raised a total of $41.81M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $28.5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $41.81M
  • Total Rounds 4
  • Last Round Series B β€” $28.5M
  • First Round $2.89M

    (Nov 2021)

  • Investors Count 6

All 4 funding rounds of Innoventric with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2024$28.5MSeries B–RA Capital Management
Jun 2022$2.66MGrant––
Nov 2021$2.89MGrant––
Nov 2021$13.31MSeries A–EIC Fund
–
Valuation history

6 investors in total: 6 institutional.

Investors in Innoventric

Innoventric has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include RA Capital, European Union and Mivtach Shamir Holdings.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investment and technology solutions are provided by BRM Group.
brm.comTel Aviv, Israel
Private fund focused on debt and equity investments in real estate, tech, energy, and multiple sectors
1958msgroup.co.ilTel Aviv, Israel
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
2004racap.comBoston, United States
Provides diversified investment management services to clients.
2017jginvest.comBeijing, China
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Innoventric

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Innoventric

7 people are tracked at Innoventric (6 in leadership, 1 in team).

NameRoleGroup
Rafi Benary
FounderLeadership
David Planer
Founder & CMOLeadership
Amir Danino
Founder & CEOLeadership
yair pichersky
Head Of R&dLeadership
Eyal Kislev
Head Of EngineeringLeadership
Einat Har
Chief Financial OfficerLeadership
Michal Krieger
Office ManagerTeam
Premium access

Complete people profiles for Innoventric

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Innoventric

3 dated milestones of Innoventric across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Innoventric is founded.
  2. Funding First funding round of $2.9M.
  3. Funding Latest funding round, Series B, of $28.5M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Innoventric

Premium access

Complete news archive for Innoventric

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Innoventric

Innoventric was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Innoventric is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.

Innoventric is a funded company, having raised a total of $41.81M across 4 funding rounds to date. The company's 1st funding round was a Grant of $2.89M, raised on Nov 2021.

Founded in 2017 in Ness Ziona, Israel, transcatheter solutions are developed for patients with heart diseases. Focus is placed on percutaneous devices, including the Trillium, which addresses tricuspid regurgitation through minimally invasive procedures. Operations occur within the medical device sector, emphasizing cardiovascular treatments. Geography is centered in Israel, with activities aimed at advancing interventional cardiology options for clinical use.

Innoventric offers Trillium, Unica, and Koala.

Innoventric has 6 investors. Key investors include RA Capital, European Union, Mivtach Shamir Holdings, BRM, and JG Investment.

Innoventric operates through Innoventric Ltd..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available